New research suggests chronic migraine may be linked to glucose dysregulation. Read the story of a writer who found freedom from chronic migraine through targeted dietary intervention based on this ...

You don’t have to suffer an endless migraine attack. Learn the signs of status migrainosus, what treatments can break the ...

Recent research shows that GLP-1s may help reduce the need for emergency care in those with chronic migraine. This research ...

COLORADO SPRINGS, Colo. -- Every 12 weeks, Shannon Stone goes to her neurologist to get Botox injected in and around her head. Not for cosmetic reasons, but for chronic migraines. “I’ve been working ...

Real-world data suggest GLP-1 receptor agonists may reduce emergency care visits and the need for additional migraine treatments in adults with chronic migraine.

Add Yahoo as a preferred source to see more of our stories on Google. Migraine sufferers may benefit from new therapies that address prevention. Marion Groening/SZ ...

Migraine affects about 12 to 13 percent of the population worldwide, with over one million people suffering from it in ...

Taking GLP-1 RAs is associated with fewer hospitalizations overall and less need for medications used to stop and prevent ...

For the millions of women living with chronic migraine, the thought of being stuck on a plane, train, or highway mid-attack is enough to spike anxiety before a trip even begins. Whether it’s time-zone ...

Migraine can have a debilitating effect on a person’s quality of life, with diagnosis and care often complicated by pervasive misconceptions and a lack of early preventive treatment. This virtual ...

GLP-1 drugs have been linked to everything from weight loss to a lower risk of developing cardiovascular disease, with new benefits coming out all the time. But while the latest potential perk seems a ...

Chronic migraine can be a debilitating medical condition. Healthline spoke with four people managing migraine and raising awareness to help others. Migraine is a complex neurological condition. While ...